Liver Aisp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2020-02-28
Share capital
14 000,00 PLN
Activity description

Liver Ai is a technology that supports the diagnosis of liver cirrhosis and associated oncological changes using computed tomography data. Its AI modules create a detailed 3D image, segment and sharpen the liver to help identify fibrosis; the system can reduce the contrast agent dose by up to 30% and shorten radiation exposure time.

Registered address
pl. Jana Kilińskiego 2, 35-005 Rzeszów, Poland
Website
liverai.plWebsite active
Electronic delivery address
AE:PL-69596-74566-EJFAG-20

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 8.44kMedianUSD 72.17kAverageUSD 3.11m
Net profit
This companyUSD -2.78kMedianUSD 69.14AverageUSD 80.67k
Operating costs
This companyUSD 11.23kMedianUSD 75.48kAverageUSD 2.93m
Assets
This companyUSD 18.52kMedianUSD 121.09kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2020-05-21. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid for SME access to finance — aid for start-ups
$205.1K

Tenders

No recorded participation in tenders.

Authorized Representatives

Paweł Wojtkowiak – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board is authorized to make declarations of will on behalf of the company independently; in the case of a multi-member management board, joint action by two members of the management board or by a member of the management board with a commercial proxy is required.

Ownership

OwnerSharesShare valueStake
Deletta Sp. z o.o.
70$945.4325%
Maciej Jan Stanuch (32)
84$1,134.5230%
Paweł Wojtkowiak (42)
126$1,701.7845%

Beneficial owners

Person

Competitors

Name
Digital Pathology Teamsp. z o.o.
ATER Netsp. z o.o.
Ai4isp. z o.o.
OPTI Gsp. z o.o.
Medaisp. z o.o.
Diamaticsp. z o.o.
IncellvuS.A.

Change history

DateEvent
2026-01-12Business suspended
2020-02-28Entered in the register

FAQ

Last updated: 2026-07-30